Evidence map›Paper›PMID 27624383›Full record

ArticleOncology research2017

Overexpression of miR-140 Inhibits Proliferation of Osteosarcoma Cells via Suppression of Histone Deacetylase 4.

Qianren Xiao, Lu Huang, Zhongzu Zhang, Xiang Chen, Jiaquan Luo, Zhanmin Zhang, Shaoqing Chen, Yong Shu, Zhimin Han, Kai Cao

Open access · hybridAbstract read
In one paragraph

Article in Oncology research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Osteosarcoma and Metastasis.Frontiers in oncology · 2021
    Review
  10. Article
  11. Autophagy · 2020
    Article
  12. Review
  13. Review
  14. Article
  15. miRNA signatures in childhood sarcomas and their clinical implications.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Qianren XiaoDepartment of Orthopedics, The First Affiliated Hospital of Nanchang University, Nanchang, P.R. China.
Lu Huang
Zhongzu Zhang
Xiang Chen
Jiaquan Luo
Zhanmin Zhang
Shaoqing Chen
Yong Shu
Zhimin Han
Kai Cao
First Affiliated Hospital of Nanchang University · CNNanchang University · CNChongqing Medical University · CNJiangxi Maternal and Child Health Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

miRNAs play a pivotal role in the development and progression of osteosarcoma (OS). Previous studies indicated that miR-140 acts as a tumor suppressor in many cancers. However, its accurate expression and exact function in OS cells remain unknown. Herein, we demonstrated the lower expression of miR-140 in 40 paired OS tissues. Restoring miR-140 expression in OS cells had a marked effect on inhibiting cell proliferation and invasion, inducing cell apoptosis in vitro, and suppressing tumor growth in vivo. Moreover, a bioinformatics prediction indicated that the histone deacetylase 4 (HDAC4) is a target gene of miR-140 and is involved in miR-140-mediated suppressive effects. In conclusion, our findings show that miR-140 acts as a tumor suppressor in OS by targeting HDAC4.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsBone NeoplasmsCell Line, TumorCell ProliferationCell SurvivalHistone DeacetylasesHumansMiceMice, NudeMicroRNAsOsteosarcomaRepressor ProteinsXenograft Model Antitumor AssaysHDAC4 protein, humanHistone DeacetylasesMicroRNAsMirn140 microRNA, humanRepressor Proteins

Identifiers

PMID27624383
PMCPMC7840736
OpenAlexW2546410955

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.